DBS Group Research has initiated coverage on AvePoint with a “buy” call at a target price of $28, implying a 42% upside from its SGX debut price. (SGX:S68
)
AvePoint, which listed on SGX on Sept 19, closed at $19.70 on its first day of trading. The dual listing, alongside its Nasdaq counter, is expected to lift brand visibility among government and regulated-industry clients in Asia, notes DBS analyst Sachin Mittal
DBS Group Research has initiated coverage on AvePoint with a “buy” call at a target price of $28, implying a 42% upside from its SGX debut price.
AvePoint, which listed on SGX on Sept 19, closed at $19.70 on its first day of trading. The dual listing, alongside its Nasdaq counter, is expected to lift brand visibility among government and regulated-industry clients in Asia, notes DBS analyst Sachin Mittal
DBS Group Research has initiated coverage on AvePoint with a “buy” call at a target price of $28, implying a 42% upside from its SGX debut price.
AvePoint, which listed on SGX on Sept 19, closed at $19.70 on its first day of trading. The dual listing, alongside its Nasdaq counter, is expected to lift brand visibility among government and regulated-industry clients in Asia, notes DBS analyst Sachin Mittal
See also: 22 April Publish To App Yes Reveal Stories No
DBS Group Research has initiated coverage on AvePoint with a “buy” call at a target price of $28, implying a 42% upside from its SGX debut price.
AvePoint, which listed on SGX on Sept 19, closed at $19.70 on its first day of trading. The dual listing, alongside its Nasdaq counter, is expected to lift brand visibility among government and regulated-industry clients in Asia, notes DBS analyst Sachin Mittal
DBS Group Research has initiated coverage on AvePoint with a “buy” call at a target price of $28, implying a 42% upside from its SGX debut price.
See also: Riverstone shares surge on UOB Kay Hian's higher target price of 98 cents led by AI-end demand
AvePoint, which listed on SGX on Sept 19, closed at $19.70 on its first day of trading. The dual listing, alongside its Nasdaq counter, is expected to lift brand visibility among government and regulated-industry clients in Asia, notes DBS analyst Sachin Mittal
DBS Group Research has initiated coverage on AvePoint with a “buy” call at a target price of $28, implying a 42% upside from its SGX debut price.
AvePoint, which listed on SGX on Sept 19, closed at $19.70 on its first day of trading. The dual listing, alongside its Nasdaq counter, is expected to lift brand visibility among government and regulated-industry clients in Asia, notes DBS analyst Sachin Mittal
DBS Group Research has initiated coverage on AvePoint with a “buy” call at a target price of $28, implying a 42% upside from its SGX debut price.
AvePoint, which listed on SGX on Sept 19, closed at $19.70 on its first day of trading. The dual listing, alongside its Nasdaq counter, is expected to lift brand visibility among government and regulated-industry clients in Asia, notes DBS analyst Sachin Mittal
DBS Group Research has initiated coverage on AvePoint with a “buy” call at a target price of $28, implying a 42% upside from its SGX debut price.
AvePoint, which listed on SGX on Sept 19, closed at $19.70 on its first day of trading. The dual listing, alongside its Nasdaq counter, is expected to lift brand visibility among government and regulated-industry clients in Asia, notes DBS analyst Sachin Mittal
For more stories about where money flows, click here for Capital Section
DBS Group Research has initiated coverage on AvePoint with a “buy” call at a target price of $28, implying a 42% upside from its SGX debut price.
AvePoint, which listed on SGX on Sept 19, closed at $19.70 on its first day of trading. The dual listing, alongside its Nasdaq counter, is expected to lift brand visibility among government and regulated-industry clients in Asia, notes DBS analyst Sachin Mittal
DBS Group Research has initiated coverage on AvePoint with a “buy” call at a target price of $28, implying a 42% upside from its SGX debut price.
AvePoint, which listed on SGX on Sept 19, closed at $19.70 on its first day of trading. The dual listing, alongside its Nasdaq counter, is expected to lift brand visibility among government and regulated-industry clients in Asia, notes DBS analyst Sachin Mittal
DBS Group Research has initiated coverage on AvePoint with a “buy” call at a target price of $28, implying a 42% upside from its SGX debut price.
AvePoint, which listed on SGX on Sept 19, closed at $19.70 on its first day of trading. The dual listing, alongside its Nasdaq counter, is expected to lift brand visibility among government and regulated-industry clients in Asia, notes DBS analyst Sachin Mittal
DBS Group Research has initiated coverage on AvePoint with a “buy” call at a target price of $28, implying a 42% upside from its SGX debut price.
AvePoint, which listed on SGX on Sept 19, closed at $19.70 on its first day of trading. The dual listing, alongside its Nasdaq counter, is expected to lift brand visibility among government and regulated-industry clients in Asia, notes DBS analyst Sachin Mittal
DBS Group Research has initiated coverage on AvePoint with a “buy” call at a target price of $28, implying a 42% upside from its SGX debut price.
AvePoint, which listed on SGX on Sept 19, closed at $19.70 on its first day of trading. The dual listing, alongside its Nasdaq counter, is expected to lift brand visibility among government and regulated-industry clients in Asia, notes DBS analyst Sachin Mittal
DBS Group Research has initiated coverage on AvePoint with a “buy” call at a target price of $28, implying a 42% upside from its SGX debut price.
AvePoint, which listed on SGX on Sept 19, closed at $19.70 on its first day of trading. The dual listing, alongside its Nasdaq counter, is expected to lift brand visibility among government and regulated-industry clients in Asia, notes DBS analyst Sachin Mittal
DBS Group Research has initiated coverage on AvePoint with a “buy” call at a target price of $28, implying a 42% upside from its SGX debut price.
AvePoint, which listed on SGX on Sept 19, closed at $19.70 on its first day of trading. The dual listing, alongside its Nasdaq counter, is expected to lift brand visibility among government and regulated-industry clients in Asia, notes DBS analyst Sachin Mittal
DBS Group Research has initiated coverage on AvePoint with a “buy” call at a target price of $28, implying a 42% upside from its SGX debut price.
AvePoint, which listed on SGX on Sept 19, closed at $19.70 on its first day of trading. The dual listing, alongside its Nasdaq counter, is expected to lift brand visibility among government and regulated-industry clients in Asia, notes DBS analyst Sachin Mittal
DBS Group Research has initiated coverage on AvePoint with a “buy” call at a target price of $28, implying a 42% upside from its SGX debut price.
AvePoint, which listed on SGX on Sept 19, closed at $19.70 on its first day of trading. The dual listing, alongside its Nasdaq counter, is expected to lift brand visibility among government and regulated-industry clients in Asia, notes DBS analyst Sachin Mittal
DBS Group Research has initiated coverage on AvePoint with a “buy” call at a target price of $28, implying a 42% upside from its SGX debut price.
AvePoint, which listed on SGX on Sept 19, closed at $19.70 on its first day of trading. The dual listing, alongside its Nasdaq counter, is expected to lift brand visibility among government and regulated-industry clients in Asia, notes DBS analyst Sachin Mittal
